Mergers & Acquisitions

Sangro to be Acquired by Axcel

pending
6564 Sangro NT PENDING

M&A Engagement Overview

Industry Group: Healthcare & Life Sciences 
Areas of Focus: Medical Products and Devices, Specialty Distribution

Harris Williams is advising GHD GesundHeits GmbH Deutschland, a portfolio company of Nordic Capital, on the pending sale of their subsidiary Sangro GmbH, to Axcel. Sangro is a mission-critical medical products distribution company serving over 3,200 medical supply stores and homecare providers and delivering over one million patients throughout Germany.

Sangro operates in a resilient and growing market with rising demand for homecare products and services, driven by an aging population, an increasing prevalence of chronic disease, and a shift towards outpatient and at-home care.

With a diversified and high-quality product offering from over 220 manufacturers across wound, ostomy and incontinence care, nutrition and medical aids, Sangro is a leading distributor and logistics provider in the German homecare market, with nationwide coverage and long-standing supplier and customer relationships. In addition to distribution, Sangro provides value-added services, including product selection guidance, inventory management, and documentation handling.

Sangro will be carved out of GHD GesundHeits GmbH, owned by Nordic Capital, and will operate as an independent company upon completion of the transaction, which is expected in the first half of 2026.

With Axcel’s backing, Sangro will gain an experienced partner for their next chapter as an independent company, enabling them to further expand their footprint, win new customers, and strengthen the important services they provide.

Contact the Harris Williams Healthcare & Life Sciences Group to learn more about this client engagement.